What is Senna Intelligence?

Senna Intelligence is a global business intelligence platform that delivers institutional-grade research, news, and analysis on deals, investments, and market trends across international markets. The platform provides real-time intelligence on global financial markets, corporate developments, and business opportunities.

What markets does Senna cover?

Senna provides comprehensive coverage of global markets including: Europe (London, Frankfurt, Paris), North America (New York, Toronto), Asia-Pacific (Singapore, Hong Kong, Tokyo), and emerging markets. We track investments, M&A deals, IPOs, market indices, and economic developments across these markets.

What does Senna offer for business intelligence?

Senna provides: (1) Global Business News - Breaking news on investments, deals, and market developments; (2) Deal Intelligence - Analysis of M&A transactions, private equity activity, and corporate finance; (3) Market Analysis - In-depth research on sectors, economic trends, and investment opportunities; (4) Professional Network - Connect with business professionals and decision-makers globally.

Who is Senna designed for?

Senna is designed for business professionals, investors, and executives interested in global markets. This includes investment professionals, corporate development teams, fund analysts, private equity professionals, entrepreneurs, and anyone seeking business intelligence on international markets.

What sectors does Senna cover?

Senna covers all major sectors globally including: Technology and Fintech, Real Estate and Infrastructure, Energy and Renewables, Healthcare, Financial Services and Banking, Consumer and Retail, E-commerce, Manufacturing and Industrials. We provide sector-specific analysis tailored to global market dynamics.

Senna

The Smart Way to Land Internships

PE investor group to sell clinical trial data firm Clario to Thermo Fisher Scientific for $8.9bn

1 min read

Home
PE investor group to sell clinical...

PE investor group to sell clinical trial data firm Clario to Thermo Fisher Scientific for $8.9bn

October 29, 2025 1 min read Follow

Executive Summary

Real-time Market Intelligence

PE investor group to sell clinical trial data f...

This $8.9bn transaction represents significant deal activity. Market participants including Thermo Fisher Scientific are actively engaged.

Updated Oct 29, 2025

Deal Value Comparison

Source: Senna Research

Chart Analysis

YTD High leads with 12.5 bn, the highest value across all 4 categories analyzed.
YTD Low trails at the lowest position with 3.1 bn, a 75% gap from the leader.
The average across all categories is 7.8 bn.
2 out of 4 categories perform above average.

Strategic Drivers

Source: Senna Research

Chart Analysis

Market Position dominates with 35.0% market share, representing the largest segment in this distribution.
The second largest segment is Growth Potential at 28.0%, trailing by 7.0 percentage points.
The remaining 2 segments collectively represent 37.0% of the total.

Premium Analysis

Subscribe to unlock full market intelligence

Data Extract

	A	B	C
1	Deal Value Comparison
2	Item	Value	Type
3	This Deal	8.9 bn	Highlighted
4	Sector Avg	6.7 bn	Data
5	YTD High	12.5 bn	Data
6	YTD Low	3.1 bn	Data
7	Source	Senna Research
8
9	Strategic Drivers
10	Item	Value	Type
11	Market Position	35%	Share
12	Growth Potential	28%	Share
13	Synergies	22%	Share
14	Other	15%	Share
15	Source	Senna Research
16
17	Article Info
18	Original Source	PE Hub	External
19	Published	Oct 29, 2025	Date
20	Reading Time	1 min	Estimate

Ask Senna Ask about this article... AI